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I. Tuccimei,2 C. Cavazzini,2 F. Mariotti,2 Y. Sun1 and J. Gay11Saint Joseph Hospital, Marseille, France; and 2San Filippo Neri Hospital, Rome, ItalyObjectives. To evaluate a recent approach for the endovascular repair of thoracic aortic aneurysms and dissections
involving the aortic arch in high risk patients (HRP).
Methods. Amongst 102 thoracic aortic aneurysms and dissections, we treated 25 patients for aortic arch endovascular
exclusion after transposition of the great vessels, of which 14 (56%) had thoracic aortic arch aneurysms and 11 type A and B
chronic aortic dissections. Total transpositions were done in 15 cases (60%) and hemi-arch transpositions in 10. We then
used Talentw, Excluderw and Zenithw endografts in 12, seven and six cases, respectively.
Results. Surgical transpositions were complicated by one minor stroke, which worsened to a major stroke (4%) after
endovascular exclusion. After endovascular exclusions, two patients (8%) died from catheterization related complications.
One patient had a delayed minor stroke (4%). The successful exclusion rate was 92%. During follow-up (15G5.8 months),
one patient (4%) developed unilateral limb palsy, successfully treated by CSF drainage. The late exclusion rate remained
92%. No stent-related complications were seen.
Conclusions. Transposition of supra-aortic vessels allows the endovascular exclusion of the aortic arch in HRP. Aortic
endografting after surgical transposition proved to be feasible and offers good mid-term results. Specialized surgical centers
with both endovascular and surgical expertise are required to treat these patients.Keywords: Stentgraft; Aortic arch; Endovascular exclusion; Aneurysm; Dissection; Transposition; Relocation; Supra-aortic
great vessels; Total arch; Hemi-arch; Thoracic aortic arch; Hybrid exclusion; Combined aortic arch treatment.Introduction
The endovascular treatment of descending thoracic
aortic aneurysms and dissections allows high risk
patients (HRP) an opportunity to be treated. However,
the thoracic aortic anatomy must be favourable to the
placement of an endograft. Complex thoracic aortic
aneurysms and dissections extending to the aortic arch
are thereby excluded from conventional endovascular
therapy. Until we know the long-term results of the
endovascular approach, conventional aortic arch
surgery under cardio-pulmonary bypass (CPB)
remains the optimal treatment for low risk patients.
We have favoured a hybrid therapeutic solution in
HRP that remains less invasive than conventional
surgery. This approach involves the transposition of
the great vessels combined with endografting. Weing author. Dr Patrice Bergeron, MD, Department of
Cardiovascular Surgery, Saint-Joseph Hospital, Bues
Floor-26, Boulevard De Louvain, 13 285 Marseille
nce.
: pbergeron@hopital-saint-joseph.fr
0038 + 08 $35.00/0 q 2006 Elsevier Ltd. All rights reserreviewed the experience of two vascular centers
whose indications and techniques for the hybrid
procedure were similar and started simultaneously
in a prospective study.Methods
From May 1999 to September 2004, 102 consecutive
patients who were high risk for surgery had endo-
luminal treatment of thoracic aortic aneurysms (TAA)
or dissections (TAD) using industrial endografts in
two vascular centers. Sixty-three patients were treated
at one center and 39 at the other hospital. During the
same period, 72 (44 and 28 at center A and B,
respectively) open procedures were performed for
TAA and TAD. The cohort of this study consisted of a
subgroup of 25 patients (24.5%) who were unsuitable
for endograft deployment, and required an open
adjunctive procedure to create a proximal landing
zone in the arch. The selection criteria and treatment
protocol were the same in both centers. Pre-operativeEur J Vasc Endovasc Surg 32, 38–45 (2006)
doi:10.1016/j.ejvs.2005.12.023, available online at http://www.sciencedirect.com onved.
Table 1. Risk factors and comorbidities in patients of the cohort
Risk factors Number of
patients
Percentage in
the cohort
High blood pressure 19 76
Age over 70 17 68
Severe cardiac impairment:
cardiac valvulopathy,
ejection fraction
! 30%, previous coronary
bypass and/or MI
12 48
Chronic pulmonary disease:
(FEV1%1 l)
10 40
Previous sternotomy for
aortic repair
7 28
Great Vessels Transposition 39assessment included evaluation of patient’s risk
factors, imaging and sizing (CT-scanGcalibrated
aortography) of the aorta and iliac arteries, and a
consensual final decision following a multidisciplin-
ary staff meeting (involving a surgeon, anaesthesist,
cardiologist, radiologist, respiratory physician).Patients w
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Fig. 1. Patients’ flow according to aortic diseaInclusion criteria for aortic arch transposition and
endografting were ASA class 3 or 4, documented
cardio-pulmonary risk, and age over 50. Exclusion
criteria were ASA class 1 or 2, age below 50, the
absence of major risk factors and inadequate or small
iliac arteries (diameter below 7–8 mm and severe
tortuosity). Patients who were not suitable for
endografting and those at low risk for surgery were
treated by open surgery (three patients during the
same period). The average age of the cohort of patients
was 71.5G9.9 years old, ranging from 50 to 83, and the
male to female ratio was 5.5. Comorbidities are
presented in Table 1. Fourteen patients (56%) had
atherosclerotic thoracic aortic aneurysms (TAA) with
an average length of the diseased aorta of 242.33G
82.34 mm. Eight patients (32%) presented with a type
B thoracic aortic dissection (TAD) extending to the
arch, of which seven were chronic and one acute, and
three patients had a type A chronic dissection (Fig. 1).
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Fig. 2. Four types of extending aortic diseases we treated by hemi or total arch exclusion. Top left, CT-scan and aortography of
a focal atherosclerotic aortic arch aneurysm; top right, two CT-scan images of an extended descending thoracic aortic
aneurysm; left bottom, two CT-scan images of a secondary aortic arch aneurysm after previous endovascular exclusion. The
images are showing the aortic arch before and after total arch exclusion; right bottom, CT-scan image of a dissecting aortic
aneurysm extending to the aortic arch.
P. Bergeron et al.40abdominal aorta, while most left renal arteries arose
from the false lumen. The location of entry tear was
either at the subclavian level in the case of retrograde
dissections, or in the ascending aorta in case of
extended residual dissections after surgery of type A
dissections. Average maximum aortic diameter was
64G11.3 mm. None of the pathologies were a result of
trauma or Marfan’s syndrome. Four types of aortic
arch disease were covered by stentgrafts (Fig. 2).
In order to distinguish from Ishimaru’s anatomical
aortic classification using antegrade numbering, we
propose a ‘retrograde landing zone classification’. This
classification is based on pathophysiology and reflects
the extension of the disease and case complexity, with
respect to the need for transposition. We define four
proximal landing zones (PLZ) as seen in Fig. 3. An
endografting procedure at PLZ 1 is an ideal situation
and requires no surgical complementary step for both
aneurysms and dissections. Starting at PLZ 2 requires
either coverage or transposition of the left subclavian
artery (LSA). If the origin of the left common carotid
artery (CCA) (PLZ 3) is involved, transposition to the
right CCA via a carotido-carotid bypass must be
performed. We call this adjunctive procedure a hemi-
arch transposition. If the disease extends the full
length of the aortic arch, requiring coverage of the
innominate artery (IA), a bypass to the IA and left
CCA is performed through a median sternotomy fromEur J Vasc Endovasc Surg Vol 32, July 2006the ascending aorta. We refer to this as total-arch
transposition (Fig. 4). The PLZs must be at least 2 or
3 cm long if possible, measured on the middle center
line of the aortic arch. The terminology of hemi-arch
and total-arch transposition is used in order to
simplify the discussion, thus avoiding repetition of
the different bypasses performed. We excluded from
this study isolated LSA transpositions.
In our 25-patient experience, we performed 15 total-
arch transpositions and 10 hemi-arch transpositions
(Fig. 1). The endografts were deployed during a
second step, 1 or 2 weeks later, following the creation
of the proximal landing zone. We always used a
femoral percutaneous access and an additional percu-
taneous humeral approach was used in some instances
to mark the origin of the native innominate artery.
Carotid and vertebral artery circulation were
assessed during the aortic arch angiogram. During
the transposition procedure, the stump pressure was
checked before clamping the arch vessels. In our
institution, stump pressure is routinely used by all
vascular surgeons since we find it more convenient
than transcranial Doppler, which requires a dedicated
technician. We do not use EEG monitoring.
Hemi-arch transposition is performed via a vertical
4 cm cervical approach to both CCA. Then an 8 mm
Dacron graft is implanted between the two CCAs in a
U shape anterior to the trachea. A bypass to the LSA
Fig. 3. The ‘retrograde landing zone classification’ aimed at
illustrating the need of great vessels transposition. Z1 is the
ideal situation where the proximal landing zone allows the
deployment of the endograft without any adjunctive
procedure. Z2 relates to the case in which the aneurysm
involves the ostium of the LSA or when the proximal neck is
less than 2 cm and does not allow the landing of the
endograft. If the aortic aneurysm extends to Z3, the left CCA
must be transposed to the right CCA, and so the LSA (hemi-
arch transposition), prior to endovascular exclusion of the
aortic arch aneurysm. If the diseased portion of the aorta
extends to Z4, the three supra-aortic vessels have to be
bypassed to the ascending aorta (total-arch transposition)
before the endovascular intervention.
Great Vessels Transposition 41previously implanted on table to the U graft is made in
an end-to-side manner. The left CCA and LSA are
divided proximally.
Total arch transposition is performed through a
median sternotomy. A 12 mm Dacron graft is implanted
on the ascending aorta as proximal as possible, using
lateral clamping. A 7 or 8 mm A Dacron graft is
implanted on the 12 mm tube graft in an end-to-side
manner to create a bifurcated graft. Then the 12 mm
Dacron graft tube is anastomosed end-to-end to the
innominate artery, while the 8 mm tube is anastomosed
the same way to the right CCA. The proximal stumps of
these vessels are clamped during the anastomosis and
sutured with a 5/0 prolene suture after the bypass is
opened in order to reduce the clamping time. Depend-
ing on the patient’s anatomy, the graft was passed in
front or behind the innominate vein, which can bedivided and reconstructed if necessary. The LSA was
not bypassed, since it is often hard to reach through a
standard sternotomy. Moreover, a patent LSA may
serve as access to the aneurysm, when coiling is
necessary to treat a residual type 1 endoleak. A
retrograde type 2 endoleak will appear only if there is
an outflow from the sac, such as created by patent
intercostal arteries, which are normally thrombosed. In
one case only we observed a type 2 endoleak that was
easily treated by percutaneous occlusion of the LSA
(Fig. 5).
In one patient, the diameter of the native aorta after
total arch transposition exceeded 40 mm, which may
have been too large to ensure adequate endograft
anchorage. Therefore, following the transposition
procedure, banding of the ascending aorta was
performed distal to the IA bypass graft. Following
total-arch transposition, markers (metal clips) or wire
loops were placed at the proximal anastomosis to the
arch, to define the proximal extent of the PLZ.
Endovascular procedures were performed under
general anaesthesia in the operating room equipped
with a C arm. We started the procedure with Terumo
hydrophilic guidewires, and then we switched to
Superstiffw guidewires from Boston Scientific. Careful
surveillance of the latter is necessary to prevent
ventricular perforation. The precise positioning of the
endograft at the proximal neck was also assisted by a
pigtail catheter from the right brachial artery, injecting
contrast medium in the left oblique anterior view. We
did not use adenosine induced transient cardiac
asystole. Endografts were oversized by 20% for
aneurysms and 10% for dissections. The distal diameter
of the endograft was initially slightly reduced with non-
tapered devices. Since, this series, we have been treating
dissections with a tapered endograft whose 24 mm
distal diameter better fit the distal landing zone.
Stentgraft deployment was monitored with trans-
esophageal-echography (TEE) and intravascular ultra-
sound (IVUS) assessment for aortic dissections. We
avoided using dilatation balloons unless it was
necessitated by a residual endoleak. This was especially
true for dissections. When it was necessary, a compliant
‘Reliantw’ balloon from Medtronic or a WL Gore
trifoliate balloon was used for dilatation.
To treat aneurysms, we used a mean covered length
of 280.33G82.34 mm (184–388) with mean proximal
and distal diameters of 43.33G2.07 and 38.00G
2.19 mm, respectively, and an average endograft
number of 2.5G1.05. These values for aortic dissec-
tions were an average length of 223.33G111.01 mm
(113–335) with mean proximal and distal diameters of
43.33G2.31 and 42.00G2.00 mm, respectively, and an
average number of endografts of 2G1.Eur J Vasc Endovasc Surg Vol 32, July 2006
Fig. 4. This patient underwent a total-arch transposition prior to endografting. Left, this intra-operative view shows the
12 mm Dacron graft implanted to the proximal ascending aorta through vertical sternotomy, and anastomosed end to end to
the IA. On this graft, a 7–8 mm graft is implanted end-to-side to revascuularize the left CCA end-to-end; right, this 3D CT-
scan reconstruction shows the total transposition and the two patent bypasses before the endograft deployment.
P. Bergeron et al.42Data such as pre-operative sizes, patients’ condition,
risk factors, and post-operative control information
were collected during regular working meetings, and
they were put together in a single Excelw file.
Following hospital discharge patients were regu-
larly contacted either by mail or telephone and they
were asked to undergo both CT-scan and plain X-ray
examinations at 3 (in case of post-operative residual
minor type 1 endoleak), 6, 12, 18 and 24 months post-
operatively, and yearly there after.
Patients were seen by the surgeons after each CT-
scan examination. Interpretation of images was done
in each center by independent radiologists.
We calculated crude rates of survival, neurological
complications and endoleaks because the cohort of the
study was not large enough to carry out a life-table
analysis (minimum required: 30 records).ResultsFig. 5. Coiling of a patent LSA after total arch exclusion for an
extended aortic aneurysm.Immediate results
Following arch transposition patients were monitored
on ICU for a maximum of 24 h. The surgical
transposition step was complicated by one minor
stroke in the group of hemi-arch transposition (10
patients). In the group of total arch transposition (15
patients) one proximal dissection occurred at the site
of lateral clamping, which sealed spontaneously.
During the endovascular step, the stentgraft deploy-
ment was successful in all patients and we had noEur J Vasc Endovasc Surg Vol 32, July 2006misplacement of the endografts. We observed one
worsening minor stroke in the group of hemi-arch
transposition, while no neurological complication
occurred in the group of total arch exclusion. During
the in-hospital course, one patient had a minor stroke
within 48 h due to the occlusion of the left CCA
bypass, which was resolved by a cervical carotido–
carotid bypass. The stroke rate was 8%. Two patients
(8%) died post-operatively from catheter related
Great Vessels Transposition 43complications: one a few hours after the procedure
from left ventricle perforation due to uncontrolled stiff
guide wire movement, which could not be sealed even
after open surgery with extra-corporeal circulation.
The other patient died at 3 days from multiorgan
failure after rupture of the iliac artery. The major
adverse event (MAE) rate, including early deaths and
major strokes, was 12%. At discharge three minor
residual type-1 endoleaks (12%) were observed, and
were left untreated since they may thrombose
spontaneously in the post-operative course. These
patients underwent early surveillance at 3 months.
The first residual endoleak thrombosed spontaneously
and the second was successfully treated by graft
extension. The third was due to an uncovered entry
tear in the ascending aorta and would have required
total arch transposition, which was rejected by the
patient. We also had one type-2 endoleak in an
aneurysm from LSA, which was successfully coiled
after 1 week. We had no case of early paraplegia.Follow-up period
Three-dimensional CT-scan and X-ray examinations
were obtained for all the patients before their
discharge to serve as control images. During an
average follow-up period of 15G5.8 months, no
patient was lost to follow-up. No new late endoleaks
were observed. The aneurysmal sac exclusion rate was
100%. The rate of non-patent thoracic false lumen was
91%, while we observed 27.3% patent abdominal false
lumens, of which the maximum aortic diameter was!
50 mm. No endograft migration or fracture was
observed, nor stengraft related complications such as
aorto-esophageal fistula.
None of the patients had new cerebral neurological
adverse events. One patient (4%) developed a
unilateral lower limb deficit at 17 days and was
readmitted to hospital. The unilateral motor deficit
resolved following CSF drainage. According to
independent neurological assessment, this deficit
could be due to medullar ischemia, based on cerebral
and medullar MRI findings. One patient with COPD
died 3 months after the procedure from acute
respiratory failure, giving an overall crude survival
rate at 15 months of 88% (22/25).Discussion
Although there has been considerable progress in
endovascular techniques, anaesthesia and intensive
care management, the surgical repair of descendingthoracic aortic aneurysms and dissections remains a
high risk procedure.1,2 Based on the eight largest (over
40 patients) recent series published,3–10 the 30-day
stroke/death rate after aortic arch surgical repair is up
to 25.6% (mean 17.5%). An alternative to surgical
repair of the aortic arch is combined stentgrafts and
great vessels transposition. Inoue et al. have reported
one case of triple-branched stengraft use11 and Chuter
has recently reported a branched stentgraft to the
innominate artery.12,13 Nevertheless, we do not know
the mid-term results of this technique.
Several case reports14–18 of combined procedures
have presented solutions to treat thoracic aortic
aneurysms and dissections extending to the aortic
arch. Criado et al. published their experience with
retrograde bypass from the right common iliac artery
to the innominate artery.19,20 This alternative does not
appear satisfactory with regards to the brain vascular-
isation and must be considered as an exception.
Sternotomy has proved to be low risk, even in HRP,
allowing a more physiological antegrade blood supply
to the brain. Allenberg et al.21 reported three cases of
total arch and five hemi-arch exclusions with no
neurological complication.
We only recommend transposition of LSA when it
supplies coronary circulation through the left internal
mammary artery (LIMA), when the contralateral
vertebral artery (VA) is stenosed or hypotrophic and
when there is an incomplete fusion of both VAs at C1.
We also recommend transposing the LSA in associ-
ation with the left CCA when they are included in the
aneurysm, except during total transpositions since the
LSA is difficult to reach by median sternotomy. In all
other cases, LSA transposition is only required later if
the coverage becomes symptomatic.
Great vessels transposition appears to be safe. There
were no major strokes or deaths related to trans-
position. There were two early deaths (8%) after the
endovascular step, that were either access or guide-
wire related. The first case has now led our team to
carefully evaluate the femoral access and to not
hesitate to implant an iliac conduit by a retro-
peritoneal approach. The second case is easily
avoidable if the guidewire is not inserted through
the aortic valve into the left ventricle and strictly
controlled during all maneuvers.
In the group of total arch exclusion, no immediate
neurological complications occurred during either
surgical or endovascular steps. On the other hand, in
the group of hemi-arch exclusion, we observed one
major stroke. This may be due to catheter manipu-
lation in front of a patent innominate artery ostium, in
a patient with an atherosclerotic aorta. A possible way
to reduce embolic complications may be to performEur J Vasc Endovasc Surg Vol 32, July 2006
P. Bergeron et al.44pre-operative trans-esophageal echography (TEE) to
better select the patients. Total arch transposition
allows availability of a longer PLZ, easily reaching
3 cm in length for a better anchoring of the endograft.
It also avoids stentgraft deployment within the arch
curvature, which may cause endoleaks and migration.
In selected cases of conical or larger aortas exceeding
40 mm in diameter, the banding technique may be
useful in association with total arch transposition to
allow a better proximal landing zone.
We prefer a staged procedure for the following
reasons: the operating time is decreased; bleeding
volume is lowered; it may lower the risk of graft
infection, since endovascular and imaging manoeu-
vers are not performed in front of an open chest.
Considering our encouraging results, we have decided
in our department to extend the use of total arch
transposition to HRP with acute type A aortic
dissection. We are combining the replacement of the
ascending aorta with the transposition of the IA to the
ascending aortic graft. This allows secondary arch
coverage for recalcitrant dissection.
The future of this challenging approach is depen-
dent on whether the endografting technology will be
reliable or not.22 Improvement of stent-grafting is
needed in terms of flexibility to improve aortic arch
navigation and reduce the embolic risk. Our experi-
ence started with the Talentw endograft, but we
required several devices to cover the whole diseased
aortic portion. Thereby, we moved to longer endo-
grafts such as TAGw, Zenithw TX1 and recently the
Valiantw. Longer endografts of at least 20 cm long
allow a one piece coverage of the arch, thus avoiding
the trombone technique, which frequently leads to
endoleaks. Indeed, we believe that overlap between
endografts increases the risk of device migration and
of type 3 endoleaks. Furthermore, newly developed
endografts allow an easy deployment. Keys for
success are the selection of the best device and
selection and management of the landing zone.
Ideally, the more flexible devices such as TAGw are
preferred to treat dissections. Since, this graft was
discontinued, we have been using the tapered
LeMaitre Vascular Endofitw device, which appears
more adapted to treat chronic dissections.
In conclusion, we report mid-term results of a
staged hybrid treatment of aortic arch aneurysm and
dissection, including the first surgical transposition of
supra-aortic carotid arteries followed by an endovas-
cular procedure. Transposition of great vessels is safe
although neurological complications may occur after
secondary endograft deployment. Combined treat-
ment for HRP offers as good results as conventional
surgery for low risk patients. Total arch transpositionEur J Vasc Endovasc Surg Vol 32, July 2006may be safer than hemi-arch transposition, allowing a
better PLZ. Since, our results are encouraging, they
allow vascular surgeons to treat HRP with aortic arch
diseases. Nevertheless, meticulous technique is man-
datory in order to avoid embolic complications,
ascending aorta dissection or myocardial perforation
due to guide wires. The long-term results of this
technique are awaited.Acknowledgements
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